300 related articles for article (PubMed ID: 16169869)
1. A crossover study of short daily haemodialysis.
Goldfarb-Rumyantzev AS; Leypoldt JK; Nelson N; Kutner NG; Cheung AK
Nephrol Dial Transplant; 2006 Jan; 21(1):166-75. PubMed ID: 16169869
[TBL] [Abstract][Full Text] [Related]
2. Reduction in beta2-microglobulin with super-flux versus high-flux dialysis membranes: results of a 6-week, randomized, double-blind, crossover trial.
Pellicano R; Polkinghorne KR; Kerr PG
Am J Kidney Dis; 2008 Jul; 52(1):93-101. PubMed ID: 18423807
[TBL] [Abstract][Full Text] [Related]
3. Daily hemofiltration for end-stage renal disease: a feasibility and efficacy trial.
Jaber BL; Zimmerman DL; Teehan GS; Swedko P; Burns K; Meyer KB; Leypoldt JK
Blood Purif; 2004; 22(6):481-9. PubMed ID: 15523174
[TBL] [Abstract][Full Text] [Related]
4. Correlates of habitual physical activity in chronic haemodialysis patients.
Zamojska S; Szklarek M; Niewodniczy M; Nowicki M
Nephrol Dial Transplant; 2006 May; 21(5):1323-7. PubMed ID: 16421165
[TBL] [Abstract][Full Text] [Related]
5. Disease severity adversely affects delivery of dialysis in acute renal failure.
Schiffl H
Nephron Clin Pract; 2007; 107(4):c163-9. PubMed ID: 17975323
[TBL] [Abstract][Full Text] [Related]
6. Daily dialyses decrease plasma levels of brain natriuretic peptide (BNP), a biomarker of left ventricular dysfunction.
Odar-Cederlöf I; Bjellerup P; Williams A; Blagg CR; Twardowski Z; Ting G; Kjellstrand CM
Hemodial Int; 2006 Oct; 10(4):394-8. PubMed ID: 17014518
[TBL] [Abstract][Full Text] [Related]
7. Scope and design of the Following Rehabilitation, Economics and Everyday-Dialysis Outcome Measurements (FREEDOM) Study.
Jaber BL; Finkelstein FO; Glickman JD; Hull AR; Kraus MA; Leypoldt JK; Liu J; Gilbertson D; McCarthy J; Miller BW; Moran J; Collins AJ;
Am J Kidney Dis; 2009 Feb; 53(2):310-20. PubMed ID: 18823688
[TBL] [Abstract][Full Text] [Related]
8. Minutes to recovery after a hemodialysis session: a simple health-related quality of life question that is reliable, valid, and sensitive to change.
Lindsay RM; Heidenheim PA; Nesrallah G; Garg AX; Suri R;
Clin J Am Soc Nephrol; 2006 Sep; 1(5):952-9. PubMed ID: 17699312
[TBL] [Abstract][Full Text] [Related]
9. Vascular access survival and morbidity on daily dialysis: a comparative analysis of home and limited care haemodialysis.
Piccoli GB; Bermond F; Mezza E; Burdese M; Fop F; Mangiarotti G; Pacitti A; Maffei S; Martina G; Jeantet A; Segoloni GP; Piccoli G
Nephrol Dial Transplant; 2004 Aug; 19(8):2084-94. PubMed ID: 15213323
[TBL] [Abstract][Full Text] [Related]
10. High-efficiency short daily haemodialysis--morbidity and mortality rate in a long-term study.
Martins Castro MC; Luders C; Elias RM; Abensur H; Romão Junior JE
Nephrol Dial Transplant; 2006 Aug; 21(8):2232-8. PubMed ID: 16632557
[TBL] [Abstract][Full Text] [Related]
11. Short daily hemodialysis: blood pressure control and left ventricular mass reduction in hypertensive hemodialysis patients.
Fagugli RM; Reboldi G; Quintaliani G; Pasini P; Ciao G; Cicconi B; Pasticci F; Kaufman JM; Buoncristiani U
Am J Kidney Dis; 2001 Aug; 38(2):371-6. PubMed ID: 11479164
[TBL] [Abstract][Full Text] [Related]
12. Genomic damage and circulating AGE levels in patients undergoing daily versus standard haemodialysis.
Fragedaki E; Nebel M; Schupp N; Sebekova K; Völkel W; Klassen A; Pischetsrieder M; Frischmann M; Niwa T; Vienken J; Heidland A; Stopper H
Nephrol Dial Transplant; 2005 Sep; 20(9):1936-43. PubMed ID: 15919695
[TBL] [Abstract][Full Text] [Related]
13. Prospective randomized cross-over long-term comparison of online haemodiafiltration and ultrapure high-flux haemodialysis.
Schiffl H
Eur J Med Res; 2007 Jan; 12(1):26-33. PubMed ID: 17363355
[TBL] [Abstract][Full Text] [Related]
14. A randomized controlled trial of high-permeability haemodialysis against conventional haemodialysis in the treatment of uraemic pruritus.
Chen ZJ; Cao G; Tang WX; Lv XY; Huang SM; Qin W; Ping F; Ye T
Clin Exp Dermatol; 2009 Aug; 34(6):679-83. PubMed ID: 19175617
[TBL] [Abstract][Full Text] [Related]
15. Effect of short daily home haemodialysis on quality of life, cognitive functioning and the electroencephalogram.
Vos PF; Zilch O; Jennekens-Schinkel A; Salden M; Nuyen J; Kooistra M MP; van Huffelen AC; Sitskoorn MM
Nephrol Dial Transplant; 2006 Sep; 21(9):2529-35. PubMed ID: 16720589
[TBL] [Abstract][Full Text] [Related]
16. The effect of increasing dialysis dose in overweight hemodialysis patients on quality of life: a 6-week randomized crossover trial.
Wang W; Tonelli M; Hemmelgarn B; Gao S; Johnson JA; Taub K; Manns B;
Am J Kidney Dis; 2008 May; 51(5):796-803. PubMed ID: 18436090
[TBL] [Abstract][Full Text] [Related]
17. Phosphate removal with several thrice-weekly dialysis methods in overweight hemodialysis patients.
Tonelli M; Wang W; Hemmelgarn B; Lloyd A; Manns B;
Am J Kidney Dis; 2009 Dec; 54(6):1108-15. PubMed ID: 19619920
[TBL] [Abstract][Full Text] [Related]
18. Hospitalization rates in daily home hemodialysis versus peritoneal dialysis patients in the United States.
Kumar VA; Ledezma ML; Idroos ML; Burchette RJ; Rasgon SA
Am J Kidney Dis; 2008 Oct; 52(4):737-44. PubMed ID: 18752877
[TBL] [Abstract][Full Text] [Related]
19. Effect of treatment frequency on haemodialysis dose: comparison of EKR and stdKt/V.
Vartia A
Nephrol Dial Transplant; 2009 Sep; 24(9):2797-803. PubMed ID: 19386748
[TBL] [Abstract][Full Text] [Related]
20. Dialysis dose and frequency.
Locatelli F; Buoncristiani U; Canaud B; Köhler H; Petitclerc T; Zucchelli P
Nephrol Dial Transplant; 2005 Feb; 20(2):285-96. PubMed ID: 15598667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
